EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 155 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 6.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $247,489 | -59.6% | 28,447 | -3.9% | 0.00% | – |
| Q1 2024 | $612,039 | -10.6% | 29,610 | 0.0% | 0.00% | – |
| Q4 2023 | $684,287 | +70.9% | 29,610 | -40.9% | 0.00% | – |
| Q3 2023 | $400,467 | -23.1% | 50,121 | -16.3% | 0.00% | – |
| Q2 2023 | $520,817 | +195.9% | 59,864 | 0.0% | 0.00% | – |
| Q1 2023 | $176,000 | +80265.3% | 59,864 | -4.3% | 0.00% | – |
| Q4 2022 | $219 | -100.0% | 62,567 | -32.3% | 0.00% | – |
| Q3 2022 | $731,000 | -8.5% | 92,412 | -9.0% | 0.00% | – |
| Q2 2022 | $799,000 | -45.2% | 101,599 | -15.4% | 0.00% | – |
| Q1 2022 | $1,459,000 | +124.8% | 120,042 | +126.3% | 0.00% | – |
| Q4 2021 | $649,000 | +207.6% | 53,049 | +162.3% | 0.00% | – |
| Q3 2021 | $211,000 | +12.2% | 20,227 | -3.3% | 0.00% | – |
| Q2 2021 | $188,000 | – | 20,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $42,580,000 | 6.66% |
| Stonepine Capital Management, LLC | 329,130 | $3,344,000 | 1.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 300,000 | $3,048,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 381,145 | $3,872,000 | 1.40% |
| Samsara BioCapital, LLC | 450,000 | $4,572,000 | 0.84% |
| Altium Capital Management LP | 289,316 | $2,939,000 | 0.82% |
| VR Adviser, LLC | 700,000 | $7,112,000 | 0.77% |
| Corriente Advisors, LLC | 200,000 | $2,032,000 | 0.75% |
| RA Capital Management | 1,250,000 | $12,700,000 | 0.19% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,181,200 | $12,001,000 | 0.18% |